ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,568Medicare Part D Prescriptions Filled, Including Refills

Rank: 205 out of 625

$422K Total Retail Price of All Prescriptions

Rank: 247 out of 625

514 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,989 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
POTASSIUM CHLORIDE 322 311 1 19
PRAVASTATIN SODIUM 313 296 2 8
ZOLPIDEM TARTRATE 286 281 3 13
LEVOTHYROXINE SODIUM 269 262 4 3
OMEPRAZOLE 249 239 5 6
AMLODIPINE BESYLATE 230 222 6 1
HYDROCHLOROTHIAZIDE 228 223 7 12
LISINOPRIL 225 204 8 5
SIMVASTATIN 175 161 9 2
FUROSEMIDE 172 167 10 7
HYDROCODONE-ACETAMINOPHEN 154 105 S3 11 4
CITALOPRAM HBR 108 102 12 24
ATORVASTATIN CALCIUM 93 73 13 9
EVISTA 93 93 13 130
GABAPENTIN 92 86 15 14
METFORMIN HCL 90 81 16 10
METOPROLOL SUCCINATE 90 89 16 15
GLIMEPIRIDE 89 78 18 42
METOPROLOL TARTRATE 88 85 19 11
AZITHROMYCIN 86 79 20 40
FLUTICASONE PROPIONATE 85 76 21 32
ATENOLOL 83 73 22 22
LOSARTAN-HYDROCHLOROTHIAZIDE 77 76 23 38
RAMIPRIL 76 73 24 78
LOSARTAN POTASSIUM 75 73 25 18
DIOVAN 75 75 25 28
SYNTHROID 73 73 27 39
TAMSULOSIN HCL 71 71 28 36
SERTRALINE HCL 71 71 28 26
CRESTOR 70 64 30 17
NEXIUM 68 50 31 21
PANTOPRAZOLE SODIUM 64 56 32 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 58 32 27
AMITRIPTYLINE HCL 61 61 R 34 61
DIOVAN HCT 60 60 35 52
DIGOXIN 60 57 35 55
DONEPEZIL HCL 59 59 37 33
VERAPAMIL ER 56 56 38 103
WARFARIN SODIUM 55 55 39 20
CARVEDILOL 54 50 40 23
TRAMADOL HCL 51 38 41 16
GLIPIZIDE XL 50 47 42 83
JANUVIA 50 50 42 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.